Literature DB >> 27505112

Progression From Perianal High-Grade Anal Intraepithelial Neoplasia to Anal Cancer in HIV-Positive Men Who Have Sex With Men.

Jill Tinmouth1, Valentina Peeva, Henok Amare, Sandra Blitz, Janet Raboud, Marie Sano, Leah Steele, Irving E Salit.   

Abstract

BACKGROUND: High-grade intraepithelial neoplasia is known to progress to invasive squamous-cell carcinoma of the anus. There are limited reports on the rate of progression from high-grade intraepithelial neoplasia to anal cancer in HIV-positive men who have sex with men.
OBJECTIVES: The purpose of this study was to describe in HIV-positive men who have sex with men with perianal high-grade intraepithelial neoplasia the rate of progression to anal cancer and the factors associated with that progression.
DESIGN: This was a prospective cohort study. SETTINGS: The study was conducted at an outpatient clinic at a tertiary care center in Toronto. PATIENTS: Thirty-eight patients with perianal high-grade anal intraepithelial neoplasia were identified among 550 HIV-positive men who have sex with men. INTERVENTION: All of the patients had high-resolution anoscopy for symptoms, screening, or surveillance with follow-up monitoring/treatment. MAIN OUTCOME MEASURES: We measured the incidence of anal cancer per 100 person-years of follow-up.
RESULTS: Seven (of 38) patients (18.4%) with perianal high-grade intraepithelial neoplasia developed anal cancer. The rate of progression was 6.9 (95% CI, 2.8-14.2) cases of anal cancer per 100 person-years of follow-up. A diagnosis of AIDS, previously treated anal cancer, and loss of integrity of the lesion were associated with progression. Anal bleeding was more than twice as common in patients who progressed to anal cancer. LIMITATIONS: There was the potential for selection bias and patients were offered treatment, which may have affected incidence estimates.
CONCLUSIONS: HIV-positive men who have sex with men should be monitored for perianal high-grade intraepithelial neoplasia. Those with high-risk features for the development of anal cancer may need more aggressive therapy.

Entities:  

Mesh:

Year:  2016        PMID: 27505112     DOI: 10.1097/DCR.0000000000000644

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era.

Authors:  Joel M Palefsky
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

2.  Progression of anal intraepithelial neoplasia in HIV-positive individuals: predisposing factors.

Authors:  T McCutcheon; A T Hawkins; R L Muldoon; M B Hopkins; T M Geiger; M M Ford
Journal:  Tech Coloproctol       Date:  2019-04-23       Impact factor: 3.781

Review 3.  Human Papilloma Virus Infection and Anal Squamous Intraepithelial Lesions.

Authors:  Laura Svidler López; Luciana La Rosa
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

4.  What Is the Risk of Anal Carcinoma in Patients With Anal Intraepithelial Neoplasia III?

Authors:  Grace C Lee; Hiroko Kunitake; Holly Milch; Lieba R Savitt; Caitlin E Stafford; Liliana G Bordeianou; Todd D Francone; Rocco Ricciardi
Journal:  Dis Colon Rectum       Date:  2018-12       Impact factor: 4.585

5.  A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer.

Authors:  Mette T Faber; Kirsten Frederiksen; Joel M Palefsky; Susanne K Kjaer
Journal:  Int J Cancer       Date:  2022-06-15       Impact factor: 7.316

Review 6.  Squamous cell anal cancer: Management and therapeutic options.

Authors:  Beatrice Pessia; Lucia Romano; Antonio Giuliani; Gianni Lazzarin; Francesco Carlei; Mario Schietroma
Journal:  Ann Med Surg (Lond)       Date:  2020-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.